化學治療導致週邊神經病變之探討

Chemotherapy-Induced Peripheral Neuropathy

10.3966/168395442016061601004

吳至容(Chih-Jung Wu)；王雅容(Ya-Jung Wang)

化學治療 ； 化學治療導致週邊神經病變 ； chemotherapy ； chemotherapy-induced peripheral neuropathy(CIPN)

腫瘤護理雜誌

16卷1期（2016 / 06 / 01）

25 - 33

繁體中文

化學治療導致週邊神經病變是癌症病人常見的副作用，受到化學治療藥物的使用劑量及累積劑量而影響各級神經系統的表現。因為症狀容易被忽視，一旦發生時，即已影響病人原有的生活品質，甚至中斷了持續進行的治療計畫。在臨床實務方面，護理人員仍缺乏化學治療導致週邊神經病變的標準評估方法和治療方式，經常遇到此症狀的病人時，對症狀的成因及處置不清楚的情境下，難以提供適切的照護措施。近幾年，國際間也漸漸重視此問題，並做為腫瘤照護發展重點之一。故本文針對化學治療導致週邊神經病變之症狀、影響因素、診斷評估方法、治療方向及護理措施，做一系統性的整理及探討。

Chemotherapy induced peripheral neuropathy (PICN) is one of the common side effects in patients with cancer. The manifestation of CIPN signs and symptoms of the nerves are different based on administered dosage or cumulative dosage of antineoplastic drug. CIPN is easily missed. Therefore, when it's noted, it usually is already in the stage where the patient's quality of life is impacted and even with the scheduled chemotherapy interrupted. There is still a lack of standardized clinical assessment and managing guideline leaving the nursing staff often feeling inadequate when facing patients with the CIPN, because they are not clear on the causes or related care. This CIPN guideline issue has become an international concern in cancer care. The focus of this review is to identify the signs and symptoms, impact factors, assessment and diagnostic methods, and treatment of the CIPN.

1. Argyriou, A. A.,Bruna, J.,Marmiroli, P.,Cavaletti, G.(2012).Chemotherapy-induced peripheral neurotoxicity (CIPN): An update.Critical Reviews in Oncology/ Hematology,82(1),51-77.
2. Armstrong, T.,Almadrones, L.,Gilbert, M. R.(2005).Chemotherapy-induced peripheral neuropathy.Oncology Nursing Forum,32(2),305-311.
3. Becze, E.(2011).Neuropathy and neuropathic pain measures: Which tool is most valid?.Oncology Nursing Society Connect,26(5),14-15.
4. Binkley, J. M.,Harris, S. R.,Levangie, P. K.,Pearl, M.,Guglielmino, J.,Kraus, V.,Rowden, D.(2012).Patient perspectives on breast cancer treatment side effects and the prospective surveillance model for physical rehabilitation for women with breast cancer.Cancer,118(8, Suppl),2207-2216.
5. Binner, M.,Ross, D.,Browner, I.(2011).Chemotherapy-induced peripheral neuropathy: Assessment of oncology nurses’ knowledge and practice.Oncology Nursing Forum,38(4),448-454.
6. Carey, M.,Jefford, M.,Schofield, P.,Kelly, S.,Krishnasamy, M.,Aranda, S.(2006).Development and evaluation of an audiovisual information resource to promote self-management of chemotherapy side-effects.Support Care Cancer,14(4),361-368.
7. Carlson, K.,Ocean, A. J.(2011).Peripheral neu- ropathy with microtubule-targeting agents: Occurrence and management approach.Clinical Breast Cancer,11(2),73-81.
8. Cleeland, C. S.,Farrar, J. T.,Hausheer, F. H.(2010).Assessment of cancer-related neuropathy and neuropathic pain.Oncologist,15(2 Suppl),13-18.
9. Donald, G. K.,Tobin, I.,Stringer, J.(2011).Evaluation of acupuncture in the management of chemotherapy-induced peripheral neuropathy.Acupuncture in Medicine: Journal of the British Medical Acupuncture Society,29(3),230-233.
10. Donovan, D.(2009).Management of peripheral neuropathy caused by microtubule inhibitors.Clinical Journal Oncoloty Nursing,13(6),686-694.
11. Doorenbos, A. Z.,Berger, A. M.,Brohard-Holbert, C.,Eaton, L.,Kozachik, S.,LoBiondo-Wood, G.,Varricchio, C.(2008).Oncology nursing society putting evidence into practice resources: where are we now and what is next?.Clinical Journal Oncology Nursing,12(6),965-970.
12. Grisold, W.,Cavaletti, G.,Windebank, A. J.(2012).Peripheral neuropathies from chemotherapeutics and targeted agents: Diagnosis, treatment, and prevention.Neuro-Oncology,14(4 Suppl.),v45-54.
13. Huang, H. Q.,Brady, M. F.,Cella, D.,Fleming, G.(2007).Validation and reduction of FACT/ GOG-Ntx subscale for platinum/paclitaxel-induced neurologic symptoms: A gynecologic oncology group study.International Journal Gynecological Cancer,17(2),387-393.
14. Johansson, S.,Svensson, H.,Denekamp, J.(2000).Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients.International Journal of Radiation Oncology, Biology, Physics,48(3),745-750.
15. Park, S. B.,Goldstein, D.,Krishnan, A. V.,Lin, C. S.,Friedlander, M. L.,Cassidy, J.,Kiernan, M. C.(2013).Chemotherapy-induced peripheral neurotoxicity: a critical analysis.CA: A Cancer Journal for Clinicians,63(6),419-437.
16. Postma, T. J.,Aaronson, N. K.,Heimans, J. J.,Muller, M. J.,Hildebrand, J. G.,Delattre, J. Y.,Group, E. Q. O. L.(2005).The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20.European Journal of Cancer Care,41(8),1135-1139.
17. Schroeder, S.,Meyer-Hamme, G.,Epplee, S.(2012).Acupuncture for chemotherapy-induced peripheral neuropathy (CIPN): A pilot study using neurography.Acupuncture in Medicine: Journal of the British Medical Acupuncture Society,30(1),4-7.
18. Smith, E. M.,Cohen, J. A.,Pett, M. A.,Beck, S. L.(2010).The reliability and validity of a modified total neuropathy score-reduced and neuropathic pain severity items when used to measure chemotherapy-induced peripheral neuropathy in patients receiving taxanes and platinums.Cancer Nursing,33(3),173-183.
19. Tofthagen, C.(2010).Patient perceptions associated with chemotherapy-induced peripheral neuropathy.Clinical Journal of Oncology Nursing,14(3),E22-E28.
20. Tofthagen, C.,Donovan, K. A.,Morgan, M. A.,Shibata, D.,Yeh, Y.(2013).Oxaliplatin-induced peripheral neuropathy’s effects on health-related quality of life of colorectal cancer survivors.Support Care Cancer,21(12),3307-3313.
21. Visovsky, C.,Collins, M.,Abbott, L.,Aschenbrenner, J.,Hart, C.(2007).Putting evidence into practice: Evidence-based interventions for chemotherapy-induced peripheral neuropathy.Clinical Journal of Oncology Nursing,11(6),901-913.
22. Wang, W. S.,Lin, J. K.,Lin, T. C.,Chen, W. S.,Jiang, J. K.,Wang, H. S.,Chen, P. M.(2007).Oral glutamine is effective for preventing oxaliplatin induced neuropathy in colorectal cancer patients.The Oncologist,12,312-319.
23. Wolf, S.,Barton, D.,Kottschade, L.,Grothey, A.,Loprinzi, C.(2008).Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies.European Journal of Cancer Care,44(11),1507-1515.
24. Wonders, K. Y.,Whisler, G.,Loy, H.,Holt, B.,Bohachek, K.,Wise, R.(2013).Ten Weeks of Home-Based Exercise Attenuates Symptoms of Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Patients.Health Psychology Research,1(3),e28.
25. Wong, R.,Sagar, S.(2006).Acupuncture treatment for chemotherapy-induced peripheral neuropathy-- A case series.Acupuncture in Medicine: Journal of the British Medical Acupuncture Society,24(2),87-91.
26. World Health Organization. (2015). Cancer. Retrieved from http://www.who.int/mediacentre/factsheets/fs297/en/
27. 王緯書,林楨國,林資琛,陳維熊,姜正愷,王煥昇,陳博明, P. M.(2007)。神經傳導速率檢查可用來客觀評估oxaliplatin所引發的週邊神經病變。中華癌醫會誌，23(2)，31-40。
28. 行政院衛生福利部（2013）．民國101年主要死因分析．取自http://www.mohw.gov.tw/cht/DOS/Statistic.aspx?f_list_no =312&fod_list_no=2747 [Ministry of Health and Welfare, Taiwan, ROC(2013). 2012 The cause of death results summary table. Retrieved from http:// www.mohw.gov.tw/cht/DOS/Statistic.aspx?f_list_no=312&fod_list_no=2747]
29. 蔡婷芳, T. F.(2008)。Taiwan, ROC，National Taiwan University。

1. 蕭雅群,鄭惠蘭,劉佩婷,孫婉綾,李淑慧(2023)。降低神經毒性化療藥物引起周邊神經病變改善專案。腫瘤護理雜誌，23(1)，53-68。
2. 楊婷婷,紀慧真(2021)。一位乳癌手術患者首次接受化學治療引起周邊神經病變之護理經驗。腫瘤護理雜誌，21(增訂刊II)，57-68。